Graphical Abstract Highlights d SelO adopts a protein kinase fold with ATP flipped in the active site d SelO transfers AMP to Ser, Thr, and Tyr residues on protein substrates (AMPylation) d SelO AMPylates proteins involved in redox homeostasis d SelO protects cells from oxidative stress and regulates protein glutathionylation
INTRODUCTION
Protein kinases are an important class of enzymes that transfer phosphate from ATP to protein substrates, a process known as phosphorylation (Fischer, 2013) . Virtually every cellular activity is regulated by protein kinases, and abnormal phosphorylation has been linked to numerous diseases. More than 500 human protein kinases have been identified and assembled into an evolutionary tree known as the human kinome (Manning et al., 2002) . However, research is largely biased toward kinases with well-established roles in disease; it has been estimated that the molecular functions of more than 50% of human kinases remain uncharacterized (Fedorov et al., 2010) . Furthermore, several new kinase families have been identified that are so different they were not included on the human kinome tree. These include the Fam20 and Fam69 families of secretory pathway kinases (Dudkiewicz et al., 2013; Tagliabracci et al., 2012) and the selenocysteine (Sec)-containing protein selenoprotein-O (SelO) (Dudkiewicz et al., 2012) .
About 10% of human protein kinases are predicted to be inactive and referred to as pseudokinases because they are missing residues located in highly conserved sequence motifs believed to be required for ATP binding and catalysis (Manning et al., 2002) . Pseudokinases serve a multitude of non-catalytic roles, such as allosteric regulators or scaffolding functions (Eyers and Murphy, 2013; Kung and Jura, 2016; Taylor et al., 2013; Zeqiraj and van Aalten, 2010) . For example, the Fam20A pseudokinase binds to and increases the stability and activity of the secretory pathway kinase Fam20C, thus acting as an allosteric regulator (Cui et al., 2015) . Similarly, the HER3 pseudokinase, although reported to have low catalytic activity, serves mostly as an allosteric activator for other members of the EGFR family of receptor kinases (Jura et al., 2009; Shi et al., 2010) . These studies have highlighted the importance of pseudokinases in human biology, and their diverse signaling functions make them attractive drug targets (Bailey et al., 2015; Byrne et al., 2017) .
Pseudokinases were initially predicted to be inactive if they were missing one or more of the three critical residues known to participate in phosphotransfer in active kinases (Manning et al., 2002) . These include (1) the VAIK motif in the b3-strand, where the Lys positions the a and b phosphates of ATP for catalysis (K72 using protein kinase A; PKA nomenclature); (2) the HRD motif located in the catalytic loop, where the Asp acts as the catalytic base (PKA; D166); and (3) the DFG motif; where the Asp binds the divalent cation to coordinate the b and g phosphates of ATP (PKA; D184). However, some predicted pseudokinases have evolved compensatory mechanisms to catalyze phosphorylation by migration of active site residues including the WNK family of kinases (Min et al., 2004) and the protein O-mannosyl kinase, SGK196 (Zhu et al., 2016) . Such compensatory mutations are often difficult to identify by primary amino acid sequence alone and have resulted in the wrongful annotation of some kinases as inactive.
We previously predicted SelO to adopt a protein kinase fold (Dudkiewicz et al., 2012) . However, its sequence suggests that SelO would be an inactive pseudokinase because it lacks the catalytic Asp (PKA; D166) ( Figures 1A and S1 ). Human SelO localizes to the mitochondria and incorporates the 21 st genetically encoded amino acid Sec (Han et al., 2014; Kryukov et al., 2003) . Structurally, Sec is similar to Cys but contains a selenium atom in place of sulfur (Stadtman, 1974) . The resulting selenol group has a lower pKa than the sulfur-containing thiol group and is deprotonated at physiological pH, resulting in higher nucleophilicity and oxidoreductase efficiency (Labunskyy et al., 2014) . 25 selenoproteins are encoded in the human genome, and many are involved in cellular redox homeostasis (Kryukov et al., 2003) . In higher eukaryotes, most SelO homologs contain a single Sec near the carboxy terminus (Han et al., 2014; Kryukov et al., 2003) . In lower eukaryotes and all prokaryotes containing a SelO homolog, an invariant Cys occupies the equivalent position ( Figure 1B) . For simplicity, we will use the SelO name for the entire family regardless of whether or not the protein contains a Sec.
SelO is highly conserved, having homologs widespread among most eukaryotic taxa, and is also common in many major bacterial taxa (Dudkiewicz et al., 2012) . Despite this (small) . Conserved catalytic motif residues are highlighted black and labeled above: ion pair (I, VAIK), catalytic (C, HRD) , and Mg 2+ binding (M, DFG) . Starting residue numbers are indicated before the alignment, with omitted residue numbers in brackets. Secondary structure (SS) elements are indicated above the alignment as arrow (strand) and cylinder (helix). Cki1, S. pombe protein kinase CK1; IRAK4, human interleukin-1 receptorassociated kinase 4. The asterisk denotes the missing catalytic Asp in the SelO pseudokinases. (B) Schematic representation of the SelO protein depicting the predicted mitochondrial targeting peptide (mTP) and kinase domain. The amino acid sequences at the C terminus of the human, mouse, yeast, and E. coli proteins are shown, highlighting the Sec (U) in the human and mouse proteins and Cys (C) in the yeast and E. coli proteins. > denotes the C terminus. (C) BLAST analysis depicting the closest bacterial homologs retrieved from a search using the human protein kinases (blue) and selenoproteins (green) as queries. SelO is in red. See also Figure S1 . sequence-based indicator of a universal role across kingdoms, the molecular function of SelO is unknown. In fact, when prioritizing targets for experimental study, Koonin and colleagues listed SelO among the top ten most-attractive ''unknown unknowns'' because of phyletic spread and potential to reveal new and exciting biology (Galperin and Koonin, 2004) .
Here, we report the crystal structure of a SelO homolog, which reveals a protein kinase-like fold. Remarkably, the ATP in the active site is flipped relative to the orientation of ATP in the active site of canonical kinases. Our structural studies led us to discover that the SelO pseudokinases are in fact active enzymes, yet transfer AMP, instead of a phosphate group, to Ser, Thr, and Tyr residues on protein substrates (AMPylation, aka adenylylation). Furthermore, we uncover that SelO plays an evolutionarily conserved role in the cellular response to oxidative stress by AMPylating proteins involved in redox homeostasis. We anticipate that the results of this work will have important implications for redox biology and may have the potential to define new paradigms of cellular regulation and signal transduction.
RESULTS

SelO Is One of the Most Highly Conserved Members of the Protein Kinase and Selenoprotein Families
To demonstrate the unique conservation of SelO, we performed basic local alignment search tool (BLAST) analyses against the Representative Proteomes RP55 database limited to bacteria using known human kinase domains and selenoproteins as queries in the search. We represent conservations of these different kinase and selenoprotein families as a plot of E value versus sequence identity of the top bacterial protein returned from the search ( Figure 1C ). Our results indicate that SelO is one of the most highly conserved members of either the human protein kinase families or the various selenoprotein families. Among bacteria, SelO is ubiquitous in Proteobacteria and Cyanobacteria, while in other phyla it is less frequent. In eukaryotes, most phyla contain on average 1 SelO gene per genome, while chordates and arthropods are exceptions, having an average of 2 or 0.14 genes per genome, respectively.
SelO Adopts a Protein Kinase Fold with ATP Flipped in the Active Site
To gain insight into the function of the SelO pseudokinases, we solved the crystal structure of the SelO homolog from the gram-negative plant pathogen Pseudomonas syringae bound to an ATP derivative AMP-PNP (Figures 2A and S2A; Table  S1 ). Despite the unique sequence found in the SelO family, P. syringae SelO adopts a protein kinase-like fold consisting of 12 b strands and 22 a helices, with the kinase domain identifying a number of kinase structures as top hits using DALI or VAST structural homology search engines (i.e., aerobactin synthase IucA, the plant receptor kinase BRASSINOSTEROID INSENSITIVE 1, the human interleukin-1 receptor-associated kinase 4, and tyrosine kinase Syk). The kinase core (b4-a14) consists of a b strand-rich N lobe and an a-helical-rich C lobe connected by a flexible linker that can be superimposed onto protein kinase CK1 with a root-mean-square deviation (RMSD) of 3.5 Å over 164 Ca atoms ( Figure S2B ). The SelO N lobe in-cludes the regulatory aC helix (Figure 2A , orange) packing against the core b sheet (Figure 2A , magenta), while the C lobe includes a pseudo-catalytic loop lacking HRD, followed by an apparent activation loop. An N-terminal extension (a1-a5, white) stabilizes the N lobe b sheet, and the unique C-terminal domains, CTD1 (a15-a19) and CTD2 (a20-a22), contact the C lobe and the aC helix, respectively. There is no clear electron density for the last 12 residues, including the C-terminal Cys, suggesting that this region is disordered.
The SelO nucleotide sits in a cleft between the two lobes of the kinase domain. Remarkably, the AMP-PNP molecule is flipped in the active site when compared to canonical protein kinases. The g-phosphate, which is normally transferred to protein in a kinase reaction, is buried in a pocket between the two lobes of the kinase domain ( Figure 2B ). In fact, after superposition of the kinase domains, the SelO a-, b-, and g-phosphates occupy the positions of the typical g-, b-, and a-phosphates of protein kinases, respectively (Figures 2B, 2C, and S2C) . The binding site for the flipped nucleotide adenine base and sugar ribose is formed by unique insertions in two SelO loops: the b6-b7 (Gly-rich loop) and the b8-aC loop (colored white, Figures 2B and 2D).
SelO Transfers AMP from ATP to Protein Substrates
The flipped orientation of ATP in the active site led us to hypothesize that the SelO proteins could transfer adenosine monophosphate (AMP) to protein substrates (AMPylation) (Casey and Orth, 2018) . We incubated recombinant E. coli (ydiU), S. cerevisiae (Fmp40), and H. sapiens SelO with [g 32 P]ATP or [a 32 P]ATP of similar specific radioactivity and observed 32 P-incorporation into the wild-type (WT) proteins only when [a 32 P]ATP was used as substrate ( Figures 3A-3C ). Mutation of the active site metal-binding DFG motif in the SelO proteins abolished 32 P incorporation. E. coli and human SelO, but not the inactive mutants, were immunoreactive to an anti-Thr AMP antibody (Figures S3A and S3B) (Hao et al., 2011) . Likewise, mass spectrometry (MS) analysis revealed peptides from WT SelO proteins but not the inactive mutants, with mass shifts of 329 Da, consistent with the covalent addition of AMP to Ser, Thr, and Tyr residues ( Figures 3D and S3C ). Furthermore, E. coli SelO, but not the inactive mutant, could AMPylate the generic protein kinase substrate myelin basic protein (MBP) in a time-dependent manner ( Figure 3E ). E. coli SelO prefers ATP over other nucleotides as a co-substrate ( Figure S3D ) and displayed a K m for ATP of $2.0 mM ( Figure S3E ). Thus, the SelO pseudokinases can AMPylate protein substrates.
Unique Interactions within the SelO Active Site Facilitate Nucleotide Binding and AMPylation
Several interactions within the SelO active site contribute to the inverted orientation of the nucleotide, including K113 (PKA; K72) that coordinates the g-phosphate of ATP ( Figure 4A ). K113 extends into the active site and is stabilized by E136 from the a6/aC helix. The formation of this ion pair, which typically positions the a-phosphate of ATP, is considered a hallmark of the activated state of a protein kinase (Taylor and Kornev, 2011) . Two invariant arginines (R176 and R183) also form interactions with the g-phosphate. R176 extends into the active site from b12 and R183 lies in the flexible hinge region that connects the N lobe to the C lobe ( Figure 4A ). Mutations of K113, E136, R176, or R183 to Ala inactivate E. coli SelO ( Figure 4B ). Most kinases require a divalent cation to orient the phosphates of ATP. In the P. syringae SelO structure, Mg 2+ and Ca 2+ are bound to the aand b-phosphates of AMP-PNP and are coordinated by N253 and D262 (PKA; N171 and D184). Mutations of these residues to Ala abolished E. coli SelO activity ( Figure 4B ). SelO was predicted to be a pseudokinase because it lacks the catalytic Asp (PKA; D166), which deprotonates the phosphoacceptor hydroxyl on the protein substrate. However, we anticipate that D252 in P. syringae SelO could fulfill this role because of its conservation and its proximity to the a-phosphate of ATP. Furthermore, its mutation to Ala inactives E. coli SelO ( Figure 4B ). Collectively, the active site of P. syringae SelO reveals evolutionarily conserved interactions that provide this family of kinases with the unique ability to transfer AMP to protein substrates.
SelO Is a Redox Active Mitochondrial Protein
The N terminus of eukaryotic SelO proteins contains a predicted mitochondrial targeting peptide (mTP). When overexpressed in mammalian cells as a GFP-fusion protein, human SelO localizes to the mitochondria (Han et al., 2014) . We expressed S. cerevisiae SelO (official gene name Fmp40) in yeast as a C-terminally tagged GFP-fusion protein and observed co-localization with the mitochondrial resident protein citrate synthase ( Figure S4A ). Mitochondrial localization was dependent on the presence of the mTP (residues 1-23) because a truncated mutant of SelO failed to localize to the mitochondria ( Figure S4A ). Furthermore, we fractionated yeast extracts by sucrose-gradient centrifugation and detected endogenous SelO in fractions enriched for the mitochondrial resident protein porin (Figure S4B) . Thus, S. cerevisiae SelO is a mitochondrial protein, and its localization depends on a functional mTP.
Many mitochondrial proteins are subjected to redox regulation, including several selenoproteins. To test the redox (D) Enlarged image of the nucleotide-binding pocket of P. syringae SelO highlighting the flipped ATP-binding pocket. Two unique SelO insertions bind the flipped nucleotide, including a G90 and Y77 from the elongated G loop (gray) that form hydrogen bonds (black dotted lines) with the ribose ring and R93 that forms hydrogen bonds with the b-phosphate, as well as D125 and G126 from the b8-aC insert (light blue) forming hydrogen bonds with the nucleotide. Two Arg side chains (R176 and R183) form a unique charged pocket for the g-phosphate, with the side chains from R183 and H181 replacing the canonical ATP nucleotidebinding site. See also Figure S2 and Table S1. function of SelO, we purified the E. coli protein under nonreducing conditions and observed a doublet when the protein was resolved by non-reducing SDS-PAGE ( Figure 5A ). The faster migrating species was converted to the slower migrating species upon treatment with the reducing agent dithiothreitol (DTT). Likewise, endogenous S. cerevisiae SelO migrated as two distinct species during non-reducing SDS-PAGE and was also sensitive to DTT ( Figure 5B ). MS analysis of E. coli SelO identified an intramolecular disulfide bond between Cys272 and Cys476 ( Figure 5C ). To confirm the sites of modification, we incubated E. coli SelO with the cysteine alkylating agent 4-acetamido-4 0 -maleimidylstilbene-2,2 0 -disulfonic acid (AMS). AMS reacts with free thiols, resulting in a change in electrophoretic mobility that can be easily observed by SDS-PAGE. AMS reduced the electrophoretic mobility of WT SelO only in the presence of the reducing agent, Tris(2-carboxyethyl) phosphine (TCEP). However, AMS reduced the electrophoretic mobility of the C272A and C476A mutants in the absence of TCEP ( Figure 5D ). Collectively, these results suggest that E. coli SelO forms an intramolecular disulfide bond between a Cys in the activation loop and the Cys at the C terminus, the latter being replaced by a Sec in higher eukaryotes ( Figures  1B and 5E ).
The formation of disulfide bonds occurs primarily in the oxidizing environment of the secretory pathway. However, some mitochondrial proteins can also form disulfide or selenylsulfide bonds as part of their catalytic mechanism (Collet and Messens, 2010) . To test whether the SelO disulfide bond regulates its activity, we incubated E. coli SelO purified under non-reducing conditions, with MBP and [a 32 P]ATP, and observed low levels of AMPylation ( Figure 5F ). However, addition of DTT or the thioredoxin system that uses reducing equivalents from nicotinamide adenine dinucleotide phosphate (NADPH) to reduce disulfides markedly increased SelO activity. Therefore, E. coli SelO activity is regulated by the formation of an intramolecular disulfide bridge.
SelO AMPylates Proteins Involved in Redox Biology
Based on the chemistry of the AMPylation reaction and the location of the adenine ring of ATP in the SelO crystal structure, we reasoned that using a biotinylated ATP analog would be an efficient strategy to identify proteins AMPylated by SelO. In this reaction, biotinylated AMP would be transferred to proteins, which would greatly facilitate isolation and identification of SelO substrates. We incubated E. coli SelO with biotin-17-ATP ( Figure 6A ) and E. coli extracts ( Figure 6B ). Remarkably, several biotinylated proteins were observed in extracts incubated with WT SelO but not the inactive mutant. To identify SelO targets, we enriched biotinylated proteins by avidin pulldown and identified potential SelO substrates by MS, several of which have roles in oxidative phosphorylation and redox biology (Table S2 ). Among our top candidates are sucA, the bacterial homolog of the E1 component of the a-ketoglutarate dehydrogenase complex (Frank et al., 2007) and glutaredoxin (grx), a small thioredoxin-like protein that catalyzes the removal of covalently linked glutathione from Cys residues on proteins (deglutathionylation) (Shelton et al., 2005) .
To test whether E. coli sucA and grxA are AMPylated by SelO in cells, we co-expressed E. coli SelO or the inactive mutant with His-tagged sucA or grxA and analyzed Ni-NTA-affinity-purified proteins for AMPylation by MS. We identified AMPylated tryptic peptides on sucA and grxA that were present when co-expressed with WT but not inactive SelO ( Figure S5 ). Notably, we identified Thr405 on sucA and Tyr13 on grxA to be potential sites of modification. Protein immunoblotting of sucA using an anti-Thr AMP antibody confirmed that Thr405 was the major site of AMPylation ( Figure 6C ). Likewise, SelO AMPylated WT grxA in vitro but not the Y13F mutant ( Figure 6D ). Thus, SelO can AMPylate Thr and Tyr residues on protein substrates both in vitro and in vivo.
To determine the substrate specificity of SelO, we performed AMPylation reactions using E. coli grxA as a model substrate. Alanine substitutions of the Cys at the À2 and Pro at the À1 positions, or replacing the AMP-acceptor Tyr with a Ser or a Thr, markedly inhibited SelO-mediated AMPylation ( Figure S6A ). However, analysis of the auto AMPylation sites in E. coli, yeast, and human SelO ( Figure S3C ), and the grxA and sucA sites ( Figure S5 ), did not reveal any obvious primary sequence requirements for SelO-catalyzed AMPylation. Therefore, SelO appears to require additional factors beyond the primary amino acid sequence of the substrate. 
SelO-Mediated AMPylation Protects S. cerevisiae from Oxidative Stress
The substrates identified from the biotin pulldown experiments and the fact that Sec-containing proteins are typically involved in redox homeostasis led us to hypothesize that SelO is involved in the cellular response to oxidative stress. Yeast grown on nonfermentable carbon sources induce oxidative stress through mitochondrial respiration (Farrugia and Balzan, 2012; Grant et al., 1997) . We detected an increase in S. cerevisiae SelO protein levels in cells grown on the non-fermentable carbon sources glycerol, lactate, and acetate ( Figure 7A ). These results are consistent with previous studies showing that yeast SelO mRNA expression correlates with the stress response and is induced in respiring cells (Tu et al., 2005). , was subjected to HCD fragmentation to generate the spectrum shown. Peaks labeled with an asterisk (*) correspond to neutral loss of ammonia (À17 Da) or water (À18 Da) from fragment ions. The peak labels are color coded depending on the status of the disulfide bond (SS) for that particular ion: black, no SS; red, intact SS; and blue, asymmetric cleavage of SS, a, or b. We challenged WT and SelO-deficient S. cerevisiae with H 2 O 2 and observed a decrease in survival in SelO knockout (KO) cells ( Figure 7B ). Cell viability was fully complemented by WT SelO but not the inactive mutant. We then incubated WT and SelO KO yeast with the redox-cycling compound menadione, which increases cellular reactive oxygen species (Zadzi nski et al., 1998) . SelO-deficient yeast displayed a menadione-dependent growth defect that was fully rescued by WT S. cerevisiae SelO but not the catalytically inactive mutant ( Figure 7C ). Collectively, these results suggest that SelO-mediated AMPylation of proteins protects S. cerevisiae from oxidative stress.
SelO Regulates Global S-glutathionylation Levels in Bacteria and Yeast
The reversible oxidative modification of cysteine residues on proteins with a molecule of glutathione (S-glutathionylation) is emerging as a ubiquitous and essential mechanism for protecting proteins exposed to oxidative conditions ( Figure S6B ) (Mieyal and Chock, 2012) . Under oxidative stress, protein thiols can become reversibly oxidized to sulfenic acids that are protected from over-oxidation by S-glutathionylation. Protein S-glutathionylation is reversed by the grx family of deglutathionylation enzymes, which form a mixed disulfide intermediate to restore the free thiol on target proteins (Shelton et al., 2005) . Interestingly, Tyr13 in E. coli grxA, which is AMPylated by SelO, lies within the highly conserved redox active site of the enzyme ( 11 C-P-Y-C 14 ) and interacts with glutathione ( Figures S6C and  S6D ). Therefore, we hypothesized that SelO-mediated AMPylation of grx family members would regulate S-glutathionylation of proteins in vivo. Under normal growth conditions, SelO deficient E. coli and yeast showed a modest decrease in global S-glutathionylation as judged by protein immunoblotting using a S-glutathionylation specific antibody ( Figures 7D and 7E , respectively; lanes 1 and 2). However, when cells were treated with oxidized glutathione (GSSG) or diamide, conditions known to increase protein S-glutathionylation (Ghezzi et al., 2002 ; Sun et al., Figure 3B . See also Figure S5 and Table S2. 2012), we observed a marked decrease in S-glutathionylation levels in both bacterial and yeast SelO KO cells (Figures 7D and 7E, respectively; . Collectively, these results suggest that SelO regulates protein S-glutathionylation levels by AMPylation of the grx family of enzymes.
DISCUSSION
Our structural analysis of P. syringae SelO has unexpectedly discovered a previously unrecognized activity for a member of the protein kinase superfamily. There are other enzymes in nature that can AMPylate protein substrates on amino acid side chains, including glutamine synthase adenylyltransferase (GS ATase) (Shapiro and Stadtman, 1968), the Legionella effector DrrA/SidM , and proteins containing the Fic domain (Worby et al., 2009; Yarbrough et al., 2009 ). However, SelO is unique because it has a protein kinase fold. GS ATase and DrrA adopt an a+b nucleotidyltransferase fold and catalyze AMPylation using a conserved G-X 11 -D-X-D motif (Holm and Sander, 1995) . In DrrA, the second Asp of the motif acts as a general base to deprotonate the protein substrate Tyr, which then acts as a nucleophile on the a-phosphate of ATP (Gavriljuk et al., 2014) . Fic family proteins adopt a mainly a-helical bundle fold with a conserved H- (Kinch et al., 2009; Xiao et al., 2010) . The Fic motif His residue acts as the general base in catalysis, while the Arg positions the b-phosphate and stabilizes the developing negative charge on the a-phosphate during catalysis (Luong et al., 2010) . A second Arg just upstream of the Fic motif forms a hydrogen bond with the g-phosphate of the bound nucleotide. Interestingly, the Fic-related Doc toxin is thought to use inverted ATP to phosphorylate protein substrates (Castro-Roa et al., 2013) . Analogous to the Fic and Doc proteins, our results suggest that a flip of the ATP in protein kinases allows the switch between AMPylation and phosphorylation of protein substrates.
In each of the known folds capable of catalyzing AMPylation, a key conserved residue acts as a general base to deprotonate the protein target Tyr or Thr residue. Sequence conservation of the SelO active site suggests that the catalytic Asp that performs this function (D252 in P. syringae SelO) has migrated from the canonical position in traditional protein kinases. Accordingly, mutagenesis supports a critical role for this residue in catalysis Cells were also treated with diamide followed by DTT as a negative control. Extracts were probed with anti-glutathionylation (GSH) and E. coli GroEL (loading control). Results are representative of at least 3 independent experiments. s.e., short exposure; l.e., long exposure. (E) Representative protein immunoblots of crude mitochondrial extracts isolated from WT and SelO KO S. cerevisiae (strain MR6) following treatment of intact mitochondria with oxidized glutathione (GSSG) and/or diamide. Mitochondria were also treated with GSSG followed by DTT as a negative control. Extracts were probed with anti-glutathionylation (GSH) and S. cerevisiae porin (loading control). Results are representative of at least 3 independent experiments. See also Figure S6. ( Figure 4B ). To gain understanding of the potential SelO peptidebinding site, we superimposed the SelO kinase domain with activated FGFR2 kinase bound to a peptide substrate ( Figure S7A ) (Chen et al., 2007) . The canonical protein kinase active site Asp (PKA; D166) approaches the substrate Tyr OH from one side, while the migrated SelO active site Asp approaches from the opposite side. A Pro residue at the C terminus of the FGFR2 activation loop that positions the substrate peptide Tyr is replaced by a conserved aromatic residue (F82) from the SelO Gly-rich loop insert. Two additional SelO family conserved residues from the Gly-rich loop insert (Q81) and the b8-aC insert (R122) that define the flipped ATP site, might also contribute to an extended SelO peptide substrate binding site.
The SelO C-terminal domains (CTDs) bridge the regulatory aC helix with the activation loop and position the aC helix in the active conformation. This interaction resembles the activation of cyclin-dependent kinase CDK2 by cyclin A (Jeffrey et al., 1995) . The CDK2 regulatory aC helix PSTAIRE motif retains a conserved RE (PKA; E91) in the same position as the invariant RE from SelO (Figures S7B and S7C) . The Arg residues from both kinases form key hydrogen bond interactions with the activation loops, while the Glu residues form an ion pair with their corresponding Lys (PKA; K72) marking the activated state of the protein kinase. In the absence of cyclin, the aC helix and the activation loop of free CDK2 adopt alternate conformations, rendering the kinase inactive. The free CDK2 regulatory helix rotates away from the active site pocket, disrupting residues involved in orienting phosphate and coordinating Mg 2+ . The free CDK2 activation loop covers the active site and prevents ATP access. The SelO CTD2 prevents such a rotation of the regulatory aC helix in the present SelO structure. The disordered C terminus extending from CTD2 plays a role in inactivating the kinase by forming a disulfide bond with a Cys in the activation loop. Analogous to CDK2, this inactivation could involve a conformational change of the CTD to allow rotation of the regulatory aC helix or an alternate conformation of the activation loop driven by disulfide bond formation, or both.
Interestingly, in the crystal structure of P. syringae SelO, the conserved activation loop cysteine (C279, corresponding to C272 of E. coli SelO) is in a position compatible with formation of a disulfide bond with another cysteine, C246 (the Cb-Cb distance is 3.8 Å ). The C246 (not present in E. coli SelO) is located only seven residues away from the predicted catalytic D252. Thus, the regulatory mechanism of intramolecular disulfidebond formation may be more complex in some members of the SelO family possessing more than one cysteine in the activation loop or in the catalytic loop. Future work will be needed to confirm the physiological importance of the selenylsulfide or disulfide bond and its role in regulating AMPylation activity of SelO from different species.
We have developed a strategy using a biotinylated ATP derivative to identify SelO substrates. Notably, we identified the glutaredoxins and the E1 component of the a-ketoglutarate dehydrogenase complex, sucA, to be direct substrates of E. coli SelO. SucA is a component of the 2-oxoglutarate dehydrogenase complex, which catalyzes a rate-limiting step of the tricarboxylic acid cycle (TCA) and is thought to be a mitochondrial redox sensor (McLain et al., 2011) . Glutaredoxin is a small redox protein involved in reducing cellular disulfides and removes glutathione from Cys residues on proteins (Shelton et al., 2005) . Interestingly, grxA is AMPylated on a highly conserved active site residue, suggesting that AMPylation may regulate its activity ( Figures S6C and S6D) . Indeed, total protein S-glutathionylation levels were decreased in SelO deficient E. coli and yeast ( Figure 7D ), suggesting that AMPylation of the grx family of enzymes is an evolutionarily conserved mechanism to regulate protein S-glutathionylation levels in cells.
Tyr13 on grxA is located adjacent to the glutathione-binding cysteine residue ( Figure S6D ), and studies have indicated that the aromatic side chain of Tyr13 provides a niche for glutathione binding and subsequent deglutathionylation acitivity (Saaranen et al., 2009) . Therefore, AMPylation of Tyr13 may impose steric hinderance for glutathione binding and would inhibit the enzyme. Similar to SelO mutants, yeast glutaredoxin mutants are more sensitive to oxidative stress induced by menadione and hydrogen peroxide treatment (Luikenhuis et al., 1998) . In the case of sucA, Thr405 lies within a disordered loop in the dimerization interface ( Figures S6E and S6F) . The loop is connected to the active site that coordinates Mg 2+ (Frank et al., 2007; Wagner et al., 2011) . Studies are underway to determine whether AMPylation of sucA regulates the formation of the a-ketoglutarate dehydrogenase complex and/or affects its activity. Collectively, the highly conserved SelO sequence, AMPylation sites in substrates (grxA, sucA), and enzymatic activity suggest that SelO regulates an ancient, conserved oxidative stress defense mechanism in prokaryotes and eukaryotes.
In higher eukaryotes, SelO homologs contain a Sec, whereas a Cys is present in the equivalent position in lower eukaryotes and all prokaryotes with a SelO homolog. Most human selenoproteins have homologs in lower organisms with a Cys in place of the Sec. Incorporation of Sec is energetically expensive; however, the evolutionary advantage of using Sec as opposed to Cys is incompletely understood. Although selenoproteins are considered superior catalysts, it was recently shown that the selenoprotein glutathione peroxidase 4 (GPX4) requires its Sec to prevent irreversible over-oxidation (Ingold et al., 2018) . We propose that SelO has evolved a Sec to increase the redox potential of the resulting selenylsulfide bond and/or prevent irreversible overoxidation, both of which would regulate AMPylation activity.
In summary, we have discovered a new activity for a member of the protein kinase superfamily, which has revealed the molecular function of 1 of the 25 selenoproteins in humans. Our results highlight the structural and biochemical diversity of the protein kinase superfamily and underscore a novel mechanism of redox regulation. Importantly, our results suggest that AMPylation may be more widespread than previously appreciated and that ''inactive'' kinases should be analyzed for alternative transferase activities.
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Takeda, K., Cabrera, M., Rohde, J., Bausch, D., Jensen, O.N., and Ungermann, C. (2008) . The vacuolar V1/V0-ATPase is involved in the release of the HOPS subunit Vps41 from vacuoles, vacuole fragmentation and fusion. FEBS Lett. 582, 1558 -1563 . Taylor, S.S., and Kornev, A.P. (2011 . Protein kinases: evolution of dynamic regulatory proteins. Trends Biochem. Sci. 36, 65-77. Taylor, S.S., Shaw, A., Hu, J., Meharena, H.S., and Kornev, A. (2013) . Pseudokinases from a structural perspective. Biochem. Soc. Trans. 41, 981-986. Tu, B.P., Kudlicki, A., Rowicka, M., and McKnight, S.L. (2005) . Logic of the yeast metabolic cycle: temporal compartmentalization of cellular processes. Zeqiraj, E., and van Aalten, D.M. (2010) . Pseudokinases-remnants of evolution or key allosteric regulators? Curr. Opin. Struct. Biol. 20, [772] [773] [774] [775] [776] [777] [778] [779] [780] [781] Zhu, Q., Venzke, D., Walimbe, A.S., Anderson, M.E., Fu, Q., Kinch, L.N., Wang, W., Chen, X., Grishin, N.V., Huang, N., et al. (2016) cit1-mCherry-HygMX (pDGFP-P GAL1 -FMP40-GFP/CEN-ARS/Amp)], BY4741 cit1 mCherry pDGFP SelO 24-C[Mata leu2D0 met15D0 ura3D0 his3D1 cit1-mCherry-HygMX (pDGFP-P GAL1 -FMP40 24-C-GFP/CEN-ARS/Amp)]. Parental MR6 [Mata ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::hisG] strain was obtained from Dr. Jean-Paul di Rago and used to generate the following strains: MR6 pRS315 [Mata ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::hisG (pRS315-LEU2/CEN-ARS/Amp)], MR6 DSelO [Mata ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::hisG fmp40D::KanMX] , MR6 DSelO pRS315[Mata ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::hisG fmp40D::KanMX (pRS315-LEU2/CEN-ARS/ Amp)], MR6 DSelO pRS315-WT FMP40 [Mata ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::hisG fmp40D::KanMX (pRS315-WT FMP40/LEU2/CEN-ARS/Amp)], MR6 DSelO pRS315-D348A FMP40 [Mata ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::hisG fmp40D::KanMX (pRS315-D348A FMP40/LEU2/CEN-ARS/Amp)].
All yeast strains were grown at 30 C in the appropriate experimental growth medium as described in the methods section.
METHOD DETAILS
Reagents
Myelin basic protein (M1891-5MG), Menadione (M5625) and AMP-PNP (A2647) were purchased from Sigma. Selenomethionine containing medium was purchased from Molecular Dimensions (MD12-500). Tris(2-carboxyethyl)phosphine hydrochloride (TCEP; 20490) and 4-acetamido-4'-maleimidylstilbene-2,2 0 -disulfonic acid (AMS; A485) were purchased from Thermo Fisher. Biotin-17-ATP was purchased from Enzo life sciences (ENZ-42817). High sensitivity streptavidin HRP (21130) and high capacity streptavidin agarose resin (20357) were purchased from Pierce. Rabbit anti-GroEL antibodies were purchased from Enzo life sciences (ADI-SPS-875-D). Rabbit anti-Vma6 antibodies were a generous gift from Dr. Vincent Starai (University of Georgia, Athens). Mouse anti-porin antibodies were from Invitrogen (459500), and rabbit anti-histone H3 antibodies were from Millipore (06-755). Rabbit anti-Mia40 antibodies were a generous gift from Dr. Carla Koehler (UCLA). Rabbit anti AMP-Threonine antibodies were as described previously (Hao et al., 2011) . Mouse anti-GSH and anti-GAPDH antibodies were from Thermo.
Generation of constructs and strains
The E. coli SelO (ydiU), grxA, sucA, trxA and trxB coding sequence were amplified by PCR using Rosetta genomic DNA as a template. The Pseudomonas syringae SelO coding sequence was amplified by PCR using P. syringae DC3000 genomic DNA. The S. cerevisiae coding sequence was amplified using BY4741 genomic DNA as a template. Homo sapiens SelO cDNA clone was a generous gift from Carolyn Worby (UCSD). The amplified open reading frames were cloned into a modified pet28a bacterial expression vector (ppSumo), containing an N-terminal 6X-His tag followed by the yeast Sumo (smt3) coding sequence or pProEX2 containing an N-terminal 6X-His tag followed by a TEV protease cleavage site. BY4741 cit1-mCherry was derived from BY4741 (MATa his3D1 leu2D0 met15D0 ura3D0) using a PCR-based modification (Longtine et al., 1998) . Briefly, a mCherry and hygromycin resistance cassette with homologous sequences flanking the C terminus of the Cit1 gene was amplified by PCR. The product of the reaction was then introduced to BY4741 via a lithium acetate mediated transformation and recovered overnight in 2 mL of YPD. Recombinants were selected by plating 100 mL of the transformation on YPD agarose plates supplemented with 200 mg/mL hygromycin. Successful recombination was verified by colony PCR using primers flanking the endogenous locus and the inserted cassette.
The S. cerevisiae SelO (fmp40) gene was replaced by KANMX4 deletion cassette in the W303-1B strain background (MR6, MATa ade2-1 his3-11,15 trp1-1 leu2-3,112 ura3-1 CAN1 arg8::hisG) (Rak et al., 2007) . The cassette was amplified by PCR with primers FWD:5 0 -CGGTGATATGAGGTGATCGTGG-3 0 and REV:5 0 -GGTGCCAGTCGTTCGG-3 0 , using total gDNA isolated from fmp40::KANMX4 deletion mutant as a template (Euroscarf collection). After transformation and selection on plates supplemented with geneticin at 200 mg/mL. Deletions were verified by PCR using primers 5 0 -GAACTCCGGAATTGGACGATG-3 0 and internal primer to the KANMX4 gene 5 0 -GGATGTATGGGCTAAATGTACG-3 0 .
For yeast complementation experiments, the S. cerevisiae SelO gene containing 1000 bp upstream of the ATG and 500 bp of the 3 0 UTR was cloned into the pRS313 vector using Not1 and Spe1 endonucleases. The FMP40 gene was then subcloned into the pRS315 vector using Not1 and Sma1, which deleted $130 bp from the 3 0 UTR. The E. coli SelO (ydiU) gene was disrupted using the l red recombinase-mediated recombination system (Datsenko and Wanner, 2000) . Briefly, a tetracycline resistance cassette flanked with 50 bp homologous to the ydiU gene was amplified via PCR. The reaction product was electroporated into the Rosetta E. coli strain carrying the l red recombinase plasmid pKD46 (a generous gift from the Dr. Vanessa Sperandio). Transformants were selected by growth on LB agar plates containing tetracycline (10 mg/mL) and simultaneously cured of pKD46 by growth at 37 C overnight. Disruption of the ydiU gene was confirmed by colony PCR, using primers flanking the endogenous locus and the inserted cassette. E. coli, P. syringae, S. cerevisiae or H. sapiens SelO, cloned into ppSumo, were transformed into Rosetta DE3 cells. Cells were grown in Luria Bertani (LB) broth to OD 600 of 0.6-0.8. Protein expression was induced with 0.4 mM IPTG for 16-18 hours at room temperature. Cells were harvested by centrifugation and lysed in 50mM Tris-HCl pH 8, 300 mM NaCl, 1 mM PMSF by sonication. Cell lysates were cleared by centrifugation at 25,000 À30,000 x g for 25-30 min. The cleared lysate was incubated with washed Ni-NTA beads for one hour at 4 C. Beads were passed over a column and washed with 20 column volumes of 50 mM Tris-HCl pH 8, 300 mM NaCl, 10-25 mM imidazole. Fusion proteins were eluted with 50mM Tris-HCl pH 8, 300 mM NaCl, 300 mM imidazole. Proteins were cut overnight at 4 C with 6X-His tagged ULP Sumo protease followed by gel filtration chromatography using a Superdex 200 gel filtration column attached to an AKTA Pure FPLC chromatography system (GE Healthcare). When proteins were purified in the presence of reducing agent, 0.1% b-mercaptoethanol was added to the lysis buffer. The wash, elution and gel filtration buffers contained 1 mM DTT.
Protein purification
In vitro AMPylation assays For comparison of [g-32 P]ATP with [a-32 P]ATP, assays were performed using purified, untagged E. coli, S. cerevisiae or H. sapiens SelO in a reaction mixture containing 50 mM Tris-HCl pH 8, 5 mM MgCl 2 , 100 mM [g-32 P]ATP or [a-32 P]ATP (specific radioactivity = 3000 cpm/pmol), 5 mM DTT, and 100 mg/mL SelO proteins. Reactions were incubated at 37 C for 30 min and terminated by adding 25 mM EDTA. SDS loading buffer was then added to the samples and boiled. Reaction products were resolved by SDS-PAGE and stained with Coomassie blue.
Typically, AMPylation assays were performed in a reaction mixture containing 50 mM Tris-HCl pH 8, 5 mM MgCl 2 , 100 mM [a-32 P] ATP (SA = 500-3000 cpm/pmol), 10-50 mg/mL SelO, and 250 mg/mL of substrate (myelin basic protein or grxA). Reactions were also performed with 5 mM DTT, 0.1 mM to 2 mM excess GTP, CTP or UTP nucleotide, or with the thioredoxin system (13 mM E. coli trxA, 5 mM E. coli trxB and 200 mM NADPH). Reactions were incubated at 37 C for various time points and terminated by adding EDTA. SDS loading buffer containing 1% b-mercaptoethanol was added to samples and boiled. Samples were resolved by SDS-PAGE and stained with Coomassie blue.
For SelO point mutant AMPylation reactions ( Figure 4B ), assays were performed using Sumo tagged E. coli SelO, under the same conditions as above for 15 min using 250 mg/mL MBP as substrate. Reactions were terminated by adding EDTA and SDS loading buffer with 1% b-mercaptoethanol and boiled. Reaction products were resolved by SDS-PAGE and stained with Coomassie blue. MBP bands were excised and the incorporated radioactivity was quantified by scintillation counting using a Beckman scintillation counter.
For non-radioactive auto AMPylation reactions, untagged E. coli or human SelO was incubated in 50 mM Tris-HCl pH 8, 5 mM MgCl 2 , 100 mM ATP, 5 mM DTT for 1 hour at 37 C. Reactions were terminated by adding EDTA and SDS loading buffer with 1% b-mercaptoethanol and boiled. Reaction products were resolved by SDS-PAGE, transferred to a nitrocellulose membrane and immunoblotted with rabbit anti-Thr AMP antibody. Immunoblotting was essentially performed as described (Tagliabracci et al., 2015) . Briefly, membranes were blocked with 5% BSA for 1 hour at room temperature. The membranes were briefy rinsed with filtered 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% tween 20 (TBST). Membranes were incubated with anti-Thr AMP antibody (1:1000) diluted in 2% nonfat dry milk (Kroger) overnight at 4 C with shaking. The membranes were washed 3-4X for 10 min each with TBST at room temperature. The membranes were then probed with donkey anti-rabbit IgG, HRP linked (1:5000 in 2% milk) for 1 hour at room temperature followed by 3-4 washes with TBST and detection by chemiluminescence.
SelO reduction assay
For redox assays, 100 mg/mL (1.8 mM) untagged E. coli SelO was incubated with 0, 0.03, 0.1, 0.3 or 1 mM DTT in 50 mM Tris-HCl pH 7.5, 150 mM NaCl for 1 hour at room temperature. SDS loading buffer without reducing agent was added to samples and boiled. Samples were resolved by SDS-PAGE and stained with Coomassie blue.
Production of S. cerevisiae SelO antibodies S. cerevisiae SelO was purified as a 6X His-Sumo fusion protein as above and the His-Sumo tag was cleaved with ULP1. The untagged protein was purified by Superdex 200 gel filtration chromatography and used to inoculate rabbits for generation of rabbit anti-S. cerevisiae SelO anti-serum (Cocalico Biologicals). Total IgG was partially purified by ammonium sulfate precipitation (Kent, 1999) then passed over a HiTrap NHS-activated HP column (GE Healthcare) linked to 6X His-Sumo to remove any potential contaminating anti-Sumo IgG. Anti-S. cerevisiae SelO antibodies were affinity-purified from the flow through by coupling S. cerevisiae SelO to a new HiTrap NHS-activated HP column essentially as described (Wollweber, 1990) .
S. cerevisiae confocal microscopy
The S. cerevisiae SelO (fmp40) was cloned into a modified yeast expression vector containing a C-terminal GFP-myc tag (pDGFP) (Salomon et al., 2013) . The BY4741 cit1 mCherry strain was transformed with empty vector, pDGFP, pDGFP S. cerevisiae SelO or pDGFP S. cerevisiae SelO 24-C. Transformed cells were grown overnight in synthetic drop-out (SD) medium without uracil and containing 2% glucose. The following day, cells were harvested by centrifugation and washed three times with sterile water. Cells were placed in culture at 30 C with shaking for 8 hours in SD-medium without uracil and containing 1% Galactose / 2% Raffinose. Cells were spotted on glass coverslip and used for confocal imaging on a Zeiss LSM 800 confocal microscope.
S. cerevisiae mitochondria isolation
Yeast mitochondria were isolated as previously described (Gregg et al., 2009) . Briefly, yeast cells were pelleted by centrifugation at 3000 x g for 5 min and the cells were washed with water then resuspended in DTT buffer (100 mM Tris-HCl pH 9.4, 10mM DTT). The cells were then incubated with shaking at 30 C for 20 min and pelleted by centrifugation. Cells were washed with zymolase buffer (20 mM potassium phosphate pH 7.4, 1.2 M sorbitol) and resuspended in zymolase buffer containing lyticase. Cells were incubated at 30 C for 30 min with shaking, then pelleted by centrifugation at 2200 x g for 5 min at 4 C. The resulting spheroplasts were washed with ice cold homogenization buffer (10 mM Tris-HCl pH 7.4, 0.6 M sorbitol, 1 mM EDTA, 0.2% BSA). Spheroplasts were resuspended in ice cold homogenization buffer and lysed using a glass dounce homogenizer. Spheroplasts were then centrifuged at 1500 x g for 5 min at 4 C and the supernatant was centrifuged at 3000 x g for 5 min at 4 C. The resulting supernatant was further centrifuged at 12,000 x g for 15 min at 4 C. The pellet was resuspended in SEM buffer (10 mM MOPS KOH pH 7.2, 250 mM sucrose, 1 mM EDTA) and centrifuged at 3000 x g for 5 min at 4 C. The supernatant was centrifuged at 12,000 x g for 15 min at 4 C. The pellet, which contains enriched mitochondria, was used for SelO TCA precipitation and glutathionylation assays (see below).
S. cerevisiae sucrose gradient fractionation BY4741 or BY4741 DSelO (Dharmacon YSC1053) were grown overnight at 30 C in YPD broth (20 g/L peptone, 10 g/L yeast extract, 2% glucose) and harvested by centrifugation. Yeast cells were disrupted and fractionated as described above. The enriched mitochondrial pellet was applied to a sucrose gradient, which was prepared by overlaying 15% sucrose in EM buffer (10 mM MOPS KOH pH 7.2, 1 mM EDTA) over 30%, 45%, 60% and 75% sucrose. Proteins (2 mg) from each sucrose gradient fraction were resolved by SDS-PAGE, transferred to nitrocellulose and immunoblotted with rabbit anti-S. cerevisiae SelO, mouse anti-porin, rabbit anti-Vma6 or rabbit anti-histone H3 antibodies.
SelO TCA precipitation BY4741 or BY4741 DSelO grown in YPD broth overnight at 30 C was harvested by centrifugation. Yeast mitochondria were isolated as described above. Mitochondria (100 mg) were pelleted and resuspended in 1 mL of 10% ice cold trichloroacetic acid (TCA). Mitochondrial proteins were precipitated on ice for 1 hour, then centrifuged at 20,000 x g for 10 min at 4 C. Precipitated pellets were washed with 1 mL of ice cold acetone and centrifuged at 20,000 x g for 5 min at 4 C. Pellets were air-dried and resuspended in 200 mL of 500 mM Tris-HCl, pH 7.5, 2% SDS and 1 mM EDTA. Samples were incubated for 10 min at room temperature in the presence or absence of 5 mM DTT. SDS loading buffer without reducing agent was added to the samples, which were subsequently resolved by SDS-PAGE and transferred to nitrocellulose membrane.
SelO cysteine mutant reduction assay E. coli SelO was purified as described above in the absence of reducing agent. Untagged E. coli SelO (100 mg/mL) was incubated in the presence or absence of 1 mM TCEP and/or 5 mM AMS for 2 hours at room temperature in the dark. SDS loading buffer without reducing agent was added to samples. Samples were resolved by SDS-PAGE and stained with Coomassie blue.
Biotin-17-ATP AMPylation assay Assays were performed using purified untagged E. coli SelO in a reaction mixture containing 50 mM Tris-HCl pH 8, 5 mM MgCl 2 , 5mM DTT, 500 mM biotin-17-ATP, 200 mg/mL SelO, 300 mg/mL E. coli cell lysate or yeast mitochondrial extracts. Reactions were also performed after pretreating E. coli and yeast mitochondria with either 2 mM H 2 O 2 (E. coli) or 0.5 mM (yeast mitochondria). Biotinylation reactions were incubated at 37 C for 30 min and terminated by the addition of EDTA and SDS loading buffer with 1% b-mercaptoethanol and boiled. Reaction products were resolved by SDS-PAGE and transferred to nitrocellulose membranes. The Streptavidin HRP blot was performed as previously described (Roux et al., 2013) . Briefly, the membranes were incubated in 1X PBS containing 1% BSA and 0.2% Triton X-100 for 30 min at room temperature. The membranes were then incubated with strepdavidin-HRP at 1:40,000 dilution in 1X PBS containing 1% BSA and 0.2% Triton X-100 with shaking overnight at 4 C. Membranes were washed and blocked with 1X PBS containing 10% adult bovine serum and 1% Triton X-100 for 5 min at room temperature. Membranes were washed with 1X PBS and blots were developed using enhanced chemiluminescence (ECl) and visualized by chemiluminescence For streptavidin agarose pulldowns, reactions were terminated with EDTA, then affinity purified using streptavidin agarose as previously described (Roux et al., 2013) . Briefly, the streptavidin agarose beads containing the biotinylated proteins were washed with 2% SDS for 8 min at room temperature followed by washing with 50 mM HEPES pH 7.5, containing 0.1% deoxycholic acid, 1% Triton X-100, 1 mM EDTA and 500mM NaCl. The beads were then washed again with 10mM Tris-HCl pH 7.4, 0.5% deoxycholic acid, 0.5% NP-40, 1 mM EDTA and 250 mM LiCl followed by a final wash with 50mM Tris-HCl pH 7.4 prior to MS analysis.
In vivo sucA and grxA AMPylation assays E. coli sucA and grxA were cloned into the MCS1 of petDuet1 in frame with an N-terminal 6X His tag. E. coli SelO was cloned without a tag into the MCS2 of petDuet1. SelO D256A, sucA T405A and sucA S404A were generated by site directed mutagenesis as described (Nguyen et al., 2016) . Briefly, primers were designed using the Agilent Quick Change Primer design tool: https://www.genomics. agilent.com/primerDesignProgram.jsp and used in PCR reaction to generate the desired mutation using PfuTurbo DNA polymerase (Thermo). Reaction products were digested with Dpn1 restriction endonuclease and mutations were confirmed by sequencing plasmids. petDuet-sucA:SelO or petDuet-grxA:SelO (or mutants) were transformed into Rosetta DE3 D E. coli SelO (ydiU) strain. Cells were grown in LB broth to OD 600 = 0.6-0.8. Protein expression was induced by the addition of 0.4 mM IPTG overnight at room temperature and the His tagged proteins were purified as described above in the presence of reducing agent. His tagged proteins were further purified by Superdex 200 gel filtration column using AKTA Pure FPLC chromatography system. SucA (2 mg) was resolved by SDS-PAGE and immunoblotted with rabbit anti-Thr AMP antibody. sucA and grxA (5 mg) were resolved by SDS-PAGE in preparation for mass spectrometry.
Hydrogen peroxide viability assays The MR6 strain was transformed with the empty pRS315 vector. The MR6 D S. cerevisiae SelO strain was transformed with empty vector, WT S. cerevisiae pRS315-SelO or pRS315-S. cerevisiae SelO D348A. Exponential growth-phase cultures (OD = 1) in glucose minimal medium (0.67% Yeast Nitrogen Base, 2% glucose, leucine Drop-out amino acids, adenine 40 mg/L) were treated with 0.1 mM H 2 O 2 for 200 min with shaking at 28 C. The cell survival in the culture at time zero (before the hydrogen peroxide treatment) and after were estimated by plating the cells on the YPD-adenine plates (1% Yeast Extract, 1% bacto peptone, 2% glucose, 2% Bacto agar, adenine 40 mg/L). The % survival was normalized to the number of cells at time zero. Results are representative of three independent experiments.
Menadione viability assays BY4741 was transformed with empty pRS313 vector. BY4741 D S. cerevisiae SelO strain was transformed with empty vector, WT S. cerevisiae pRS313-SelO or pRS313-S. cerevisiae SelO D348A. Exponential growth phase cultures in glucose synthetic drop-out medium without histidine (6.7 g/L yeast nitrogen base without amino acids, 1.4 g/L yeast synthetic drop-out medium supplement and containing 2% [w/v] glucose and leucine, tryptophan, uracil; (Salomon and Sessa, 2010) , were treated with 0.6 mM menadione for 1 hour at 30 C. Post treatment, cells were serial diluted ten-fold and spotted on synthetic drop-out plates. Cells were grown for 2-3 days prior to imaging.
Mass spectrometry analysis
Sample preparation included the excision of proteins from polyacrylamide gels that were separated by SDS-PAGE and stained with Coomassie blue. Protein gel samples were reduced and alkylated using DTT and iodoacetamide, respectively. Note, reduction and alkylation of cysteine residues was not performed on the sample containing unreduced E. coli SelO peptides linked by the disulfide bond ( Figure 5 ). Enzymatic overnight digestion (37 C) was performed on all samples using trypsin or Asp-N and samples were desalted using solid phase extraction (SPE) prior to mass spectrometry analysis. LC-MS/MS experiments were performed on a Thermo Scientific EASY-nLC 1200 liquid chromatography system coupled to a Thermo Scientific Orbitrap Fusion Lumos mass spectrometer. To generate MS/MS spectra, MS1 spectra were first acquired in the Orbitrap mass analyzer with a resolution of 120,000. Peptide precursor ions were isolated and fragmented using high-energy collision-induced dissociation (HCD). The resulting MS/MS fragmentation spectra were acquired in the ion trap. MS/MS spectral data was then searched using the Mascot search engine (Matrix Science) for peptide identification. Carbamidomethylation of cysteine residues (+57.021 Da) was set as a static modification for searches, while oxidation of methionine (+15.995 Da) and AMPylation of serine/tyrosine/threonine (+329.053 Da) were set as dynamic modifications. The precursor ion tolerance was set to 15 ppm and the product ion tolerance was set to 0.6 Da for all searches. The MS/MS spectrum of the E. coli SelO peptides linked by the disulfide bond were first identified using Thermo BioPharma Finder software and confirmed via manual verification and assignment of fragment ions. Carbamidomethylation of cysteine residues was not included as a modification for this search, as the sample was not reduced/alkylated. Additionally, the identification of all AMPylated peptides were manually verified from the MS/MS spectra of the modified peptides and their unmodified counterparts. Unique ions (136.1, 250.1, and 348.1 Da) corresponding to the neutral loss of the AMP group from peptides during HCD were present in the MS/ MS spectra of AMPylated peptides.
Analysis of S. cerevisiae SelO expression
MR6 and MR6 DSelO strain was grown in YPAD overnight, then diluted into YP medium with either 2% glucose, 2% galactose, 2% raffinose, 3% glycerol, 2% potassium acetate, or 2% sodium lactate. Cells were harvested following overnight incubation at 30 C and extracts were prepared as described previously (Salomon and Sessa, 2010) . Briefly, 1OD of yeast cells were centrifuged at 800 x g for 5 min at room temperature. Cells were resuspended in 100 uL of ice cold yeast lysis buffer (200 mM NaOH and 0.5% b-mercaptoethanol) and incubated on ice for 30 min. The pH of the lysate was adjusted to $7 by the addition of 6M HCl. SDS loading buffer containing 1% b-mercaptoethanol was added and the samples were boiled prior to SDS-PAGE.
E. coli protein S-glutathionylation experiments
Rosetta and Rosetta D SelO strains were transformed with empty pBad MycHis vector. Cultures were grown in M9 minimal medium with ampicillin for 48 hours. Cells (1 OD) were resupended in 1xPBS and treated with 1 mM GSSG or 1 mM diamide for 25 min at room temperature. Post treatment, 10 mM NEM was added to the cells and incubated for 5 min at room temperature. SDS loading buffer without reducing agent was added to the samples, which were subsequently resolved by SDS-PAGE, transferred to nitrocellulose membranes and analyzed for protein S-glutathionylation using the anti-GSH antibody (Virogen/Thermo) and GroEL. Figure 6 
